Woodland Hills, CA — September 4, 2025 — The Celiac Disease Foundation today announced the launch of its Clinical Trials Site Advisory Council, a global panel of academic researchers, principal…
Continue ReadingIs celiac disease having a significant impact on your daily life? You may be eligible for a clinical study. The ASPIRION study is a phase 2 study looking into a new, investigational study drug (amlitelimab) for patients with celiac disease.
Continue ReadingWhat if there was a way to help your immune system become more tolerant of gluten? That’s the potential of VTP-1000, an investigational immunotherapy being studied in the AVALON celiac disease clinical trial.
Continue ReadingNew research from Tampere University in Finland shows exciting progress in a new drug for celiac disease. This drug, ZED1227 could be used alongside a gluten-free diet to help manage…
Continue ReadingThe Celiac Disease Foundation is committed to accelerating research aimed at finding potential treatments and cures for celiac disease beyond the gluten-free diet. In order to do this, we need…
Continue ReadingJoining research studies and clinical trials is the only way to help scientists better understand this autoimmune disease and ultimately find a cure for celiac disease. This spring, I joined one of those important trials, funded by the Foundation, to help researchers with the development of a revolutionary new screening tool for celiac disease.
Continue ReadingThe SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference.
Continue ReadingThe Celiac Disease Foundation, a trusted partner in optimizing patient recruitment and retention, announces the launch of its iRecruitCeliac platform, which brings together solutions to accelerate enrollment in clinical trials for celiac disease and comorbid conditions.
Continue ReadingWant to get involved in celiac disease research? It’s time to take action. The TEV-CeD Study is a phase 1b clinical trial testing the investigational medication TEV-53408 for the treatment of celiac disease.
Continue ReadingConsider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.
Continue ReadingDear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...